Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival.

By Jin-Ching Lin, J. Jan, Chen-yi Hsu, W. Liang, R. Jiang, Wen-Yi Wang. Journal of Clinical Oncology, 2003

742 citations recorded by the source corpus.

Subfields: Otorhinolaryngology, Pulmonary and Respiratory Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/2587dc3ef36aa47432856664ebfd678ec69e22ee

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. K. Ang
2. J. Harris
3. Nancy Y. Lee
4. A. Garden
5. W. Straube
6. B. Glisson
7. P. Xia
8. C. Jones

Citations in the corpus

• Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. (2009, positive): “The value of the adjuvant treatment is not clearly known, as at least one study did not include adjuvant chemotherapy also showed superb outcomes.(36) Because RT, whether by using IMRT or non-IMRT techniques, with chemotherapy achieved superb LR control in patients who presented with locoregionally ”